CEO
Aakha Biologics
The startup develops next-generation immunotherapies for cancer treatment using advanced antibody discovery platforms to optimize therapeutic options. By facilitating the efficient progression from concept to investigational new drug studies, the company addresses the need for effective cancer therapies in a timely manner.
- Biotechnology
Updated 5 months ago
Funding
Raised to date
$5.6MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops next-generation immunotherapies for cancer treatment using advanced antibody discovery platforms to optimize therapeutic options. By facilitating the efficient progression from concept to investigational new drug studies, the company addresses the need for effective cancer therapies in a timely manner.